---
title: "Vaxart Faces Nasdaq Delisting, Moves to OTCQX"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258147076.md"
description: "Vaxart, Inc. has been delisted from Nasdaq due to non-compliance with requirements, including shareholder approval and a reverse stock split. The company's stock is now traded on the OTCQX under the symbol 'VXRT'. Analysts rate VXRT as a Hold with a $0.50 price target, reflecting strong revenue growth but facing profitability and operational challenges. Vaxart's current market cap is $88.82M, with an average trading volume of 1,878,368 shares."
datetime: "2025-09-19T20:35:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258147076.md)
  - [en](https://longbridge.com/en/news/258147076.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258147076.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/258147076.md) | [繁體中文](https://longbridge.com/zh-HK/news/258147076.md)


# Vaxart Faces Nasdaq Delisting, Moves to OTCQX

The latest update is out from Vaxart ( (VXRT) ).

Vaxart, Inc. faced a delisting from Nasdaq after failing to meet the conditions set by the Nasdaq Hearings Panel, which included obtaining shareholder approval and completing a reverse stock split by specified dates in 2025. Consequently, Vaxart’s common stock was suspended from trading on Nasdaq and is now quoted on the OTCQX Best Market under the symbol ‘VXRT’.

The most recent analyst rating on (VXRT) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Vaxart stock, see the VXRT Stock Forecast page.

**Spark’s Take on VXRT Stock**

According to Spark, TipRanks’ AI Analyst, VXRT is a Neutral.

Vaxart’s stock score reflects strong revenue growth and promising vaccine developments, but is weighed down by profitability challenges, negative valuation metrics, and operational uncertainties.

To see Spark’s full report on VXRT stock, click here.

**More about Vaxart**

**Average Trading Volume:** 1,878,368

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $88.82M

For an in-depth examination of VXRT stock, go to TipRanks’ Overview page.

### Related Stocks

- [Vaxart, Inc. (VXRT.US)](https://longbridge.com/en/quote/VXRT.US.md)

## Related News & Research

- [Vaxart Reports Positive Phase 1 Results for Oral Norovirus Vaccine in Lactating Women](https://longbridge.com/en/news/272701495.md)
- [Vaxart Executives to Present at Global BioInnovation Forum](https://longbridge.com/en/news/271982696.md)
- [Director’s Bold Move: Major Stock Purchase at Vaxart](https://longbridge.com/en/news/267000560.md)
- [Assessing Vaxart (VXRT) Valuation As Conference Presentation Draws Increased Investor Attention](https://longbridge.com/en/news/277194568.md)
- [Vaxart Partners with Dynavax for Oral COVID-19 Vaccine](https://longbridge.com/en/news/264513399.md)